\-\ Texto\\:\\ \ \(0\)\
\-\ purulent\\ dicharge\\ and\\ tearing\\ from\\ left\\ tear\\ puncta\ \(0\)\
\-\ oral\\ antibiotics\\ \\(iv\\ antibiotics\\ if\\ orbit\\ is\\ involved\\)\\ with\\ repeat\\ imaging\\ as\\ clinically\\ indicated\\.\\ \\ probe\\ placement\\ in\\ duct\\ if\\ antibiotic\\ therapy\\ alone\\ proves\\ inadequate\\.\ \(0\)\
\-\ enlargement\\ of\\ bony\\ canal\\ of\\ left\\ nasolacrimal\\ duct\\ with\\ central\\ fluid\\ attenuation\\ and\\ non\\-calcified\\ sepations\\.\\ \\ peripheral\\ enhancement\\ of\\ left\\ canthus\\/nasolacrimal\\ duct\\ region\\.\\ \\ no\\ calcification\\ of\\ canal\\.\\ \\ \\ canthal\\ findings\\ only\\,\\ no\\ other\\ preseptal\\ or\\ postseptal\\ involvement\ \(0\)\
\-\ dacrocystitis\ \(0\)\
\-\ dacrocystitis\\ \\(dacrocystocele\\)\\ with\\ or\\ without\\ orbital\\ involvement\\.\ \(0\)\
\-\ 43\\ y\\/o\\ female\\ with\\ 1\\ month\\ history\\ of\\ purluent\\ d\\/c\\ from\\ left\\ tear\\ puncta\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dacrocystitis\\:\\ 0\\.3346893038243819\ \(0\)\
\-\ puncta\\:\\ 0\\.3198134975726181\ \(0\)\
\-\ nasolacrimal\\:\\ 0\\.2721450754281923\ \(0\)\
\-\ duct\\:\\ 0\\.27023055465193885\ \(0\)\
\-\ tear\\:\\ 0\\.1734646437959397\ \(0\)\
\-\ dicharge\\:\\ 0\\.16734465191219094\ \(0\)\
\-\ sepations\\:\\ 0\\.16734465191219094\ \(0\)\
\-\ purluent\\:\\ 0\\.16734465191219094\ \(0\)\
\-\ canal\\:\\ 0\\.16108772673180421\ \(0\)\
\-\ canthal\\:\\ 0\\.15990674878630906\ \(0\)\
\-\ postseptal\\:\\ 0\\.15462947253451756\ \(0\)\
\-\ antibiotics\\:\\ 0\\.15418380149773447\ \(0\)\
\-\ involvement\\:\\ 0\\.15147447494770555\ \(0\)\
\-\ dacrocystocele\\:\\ 0\\.1505360990613121\ \(0\)\
\-\ proves\\:\\ 0\\.14436380987910763\ \(0\)\
\-\ left\\:\\ 0\\.1427820878473983\ \(0\)\
\-\ probe\\:\\ 0\\.1397536662827538\ \(0\)\
\-\ preseptal\\:\\ 0\\.13782091968363874\ \(0\)\
\-\ tearing\\:\\ 0\\.1260466709730751\ \(0\)\
\-\ inadequate\\:\\ 0\\.12176121065328892\ \(0\)\
\-\ if\\:\\ 0\\.121598705802968\ \(0\)\
\-\ purulent\\:\\ 0\\.12029289711975985\ \(0\)\
\-\ alone\\:\\ 0\\.10292841911222826\ \(0\)\
\-\ of\\:\\ 0\\.10238946099569363\ \(0\)\
\-\ antibiotic\\:\\ 0\\.097926999581076\ \(0\)\
\-\ 43\\:\\ 0\\.097926999581076\ \(0\)\
\-\ orbit\\:\\ 0\\.09691325402753231\ \(0\)\
\-\ repeat\\:\\ 0\\.09178451402237653\ \(0\)\
\-\ orbital\\:\\ 0\\.09178451402237653\ \(0\)\
\-\ clinically\\:\\ 0\\.0869602021729452\ \(0\)\
\-\ indicated\\:\\ 0\\.0860651892425322\ \(0\)\
\-\ involved\\:\\ 0\\.0839045623684418\ \(0\)\
\-\ oral\\:\\ 0\\.08380775936684949\ \(0\)\
\-\ from\\:\\ 0\\.0831183909943807\ \(0\)\
\-\ with\\:\\ 0\\.0819605109393924\ \(0\)\
\-\ placement\\:\\ 0\\.08171161103447686\ \(0\)\
\-\ bony\\:\\ 0\\.08062485301724753\ \(0\)\
\-\ enlargement\\:\\ 0\\.08022343379978415\ \(0\)\
\-\ attenuation\\:\\ 0\\.0800652938011715\ \(0\)\
\-\ peripheral\\:\\ 0\\.07482742492486198\ \(0\)\
\-\ iv\\:\\ 0\\.0747683455622592\ \(0\)\
\-\ calcification\\:\\ 0\\.07470945586085781\ \(0\)\
\-\ or\\:\\ 0\\.07280587824227988\ \(0\)\
\-\ central\\:\\ 0\\.06987853073505894\ \(0\)\
\-\ no\\:\\ 0\\.0680564961370224\ \(0\)\
\-\ only\\:\\ 0\\.0653741172655942\ \(0\)\
\-\ month\\:\\ 0\\.06365467686329421\ \(0\)\
\-\ region\\:\\ 0\\.06259185786579807\ \(0\)\
\-\ fluid\\:\\ 0\\.06041773770221941\ \(0\)\
\-\ enhancement\\:\\ 0\\.06022986644251976\ \(0\)\
\-\ therapy\\:\\ 0\\.060123369039007474\ \(0\)\
\-\ without\\:\\ 0\\.05519449426190077\ \(0\)\
\-\ imaging\\:\\ 0\\.05499268665747303\ \(0\)\
\-\ other\\:\\ 0\\.05434204761755363\ \(0\)\
\-\ findings\\:\\ 0\\.051644812283074853\ \(0\)\
\-\ female\\:\\ 0\\.050494384196683395\ \(0\)\
\-\ and\\:\\ 0\\.043245798881398734\ \(0\)\
\-\ as\\:\\ 0\\.042038232675675\ \(0\)\
\-\ history\\:\\ 0\\.03997913774249108\ \(0\)\
\-\ is\\:\\ 0\\.02865680504207586\ \(0\)\
\-\ in\\:\\ 0\\.02603142671366323\ \(0\)\
